ABSTRACT
Michael Schafferius will explore the evolving global regulatory landscape surrounding PFAS, which increasingly impacts industries reliant on polymers such as PVDF and PTFE. This presentation highlights Sartorius’s proactive response to these challenges with the introduction of Sartopore® EVO — a sterilizing-grade filter designed without the intentional use of PFAS, supporting both sustainability objectives and compliance with tightening regulations. As restrictions escalate worldwide, including regional bans and the recent halt of PFAS production by 3M, the demand for safer, future-proof filtration solutions becomes critical. Sartopore® EVO offers biopharmaceutical manufacturers a secure, high-performance alternative to safeguard their processes and ensure supply chain resilience.
14:00 - 14:45
Beyond PFAS: Final Filtration Evolution With A New Low Binding Filter Technology
👤 Micheal Schafferius, Application Specialist for Separation Technologies, Sartorius Australia
14:45 - 15:00
Live Questions and Answers
Micheal Schafferius
Application Specialist for Separation Technologies,
Sartorius Australia
Micheal Schafferius is currently the Application Specialist for Separation Technologies at Sartorius Australia and serves as the APAC Filter Integrity Champion. He has been with Sartorius for 13 years and brings over 20 years of experience in the pharmaceutical and biopharmaceutical sectors. Micheal’s expertise encompasses Filtration, Single-Use Technologies, Quality Assurance, Validation, and Sterile Manufacturing, gained through roles with both local and international companies. He is a recognized subject matter expert in Pre-Use Post-Sterilization Integrity Testing of filters and frequently presents on this topic at regional conferences.
Micheal concluded his term as President of the Parenteral Drug Association (PDA) Australia chapter in 2024 and continues to contribute as an active core committee member.
Share With Your Network
